Sarepta Therapeutics: Sell Rating Amid Uncertain Pipeline and Financial Risks
Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Sell rating on Sarepta Therapeutics (SRPT – Research Report) and decreased the price ...
Stocktwits on MSN1h
Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges
Shares of Novocure Ltd. skyrocketed over 55% on Monday afternoon, reaching levels last seen in August 2023, as the company ...
Sarepta price target lowered to $75 from $80 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Sarepta (SRPT) to $75 from $80 and keeps a Sell rating on the shares. Sarepta’s deal to ...
bovnews5h
Syros Pharmaceuticals Inc (SYRS) Stock Rated Buy by H.C. Wainwright
H.C. Wainwright has recently raised Syros Pharmaceuticals Inc (SYRS) stock to Buy rating, as announced on November 4, 2020, according to Finviz. Earlier, on September 22, 2020, Alliance Global ...
bovnews8h
Why Did H.C. Wainwright Give Energy Fuels Inc (UUUU) Stock Buy Rating?
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
ETF Daily News1d
electroCore, Inc. Enters into At The Market Offering Agreement with H.C. Wainwright & Co., LLC
The Company clarified that they are not obligated to sell any Shares under this agreement. H.C. Wainwright & Co., LLC will act to sell the Shares based on electroCore’s instructions and within the ...
Bit Digital And Core Scientific Are Early Winners In The AI Race Among Bitcoin Miners
Core Scientific and Bit Digital have jumped to the front of the pack in the bitcoin miner AI race. Core Scientific is leading ...
Investing14d
H.C. Wainwright keeps Buy rating on Cytokinetics shares, citing promising data on aficamten and omecamtiv
On Monday, H.C. Wainwright reaffirmed a Buy rating with a $120.00 price target on shares of Cytokinetics (NASDAQ:CYTK). The firm's endorsement follows presentations at the 2024 American Heart ...
Nasdaq18d
Alumis price target lowered to $26 from $30 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Alumis (ALMS) to $26 from $30 and keeps a Buy rating on the shares following the Q3 report. TipRanks is the most comprehensive data set of sell ...
Benzinga.com19d
MARA Holdings Faces Mixed Analyst Sentiment: Revenue Miss And Conservative Forecasts Amid Bitcoin Rally
H.C. Wainwright reiterates Buy rating on MARA, noting its valuation amid Bitcoin's rise and access via ETFs. JP Morgan assigns MARA an Underweight rating, citing high valuation despite strong ...
Yahoo Finance19d
H.C. Wainwright Maintains ‘Buy’ Rating on Spectral AI, Inc. (MDAI) with $3.50 Price Target After Strong Q3 Results and Regulatory Progress
We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at where Spectral AI, Inc. (NASDAQ:MDAI) stands against the other AI stocks ...
Yahoo Finance19d
H.C. Wainwright Maintains ‘Buy’ Rating on Spectral AI, Inc. (MDAI) with $3.50 Price Target After Strong Q3 Results and Regulatory Progress
We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at where Spectral AI, Inc. (NASDAQ:MDAI) stands against the other AI stocks that ...